首页> 外文期刊>Journal of Muscle Research and Cell Motility >The stroke size of myosins: a reevaluation
【24h】

The stroke size of myosins: a reevaluation

机译:肌球蛋白的中风大小:重新评估

获取原文
获取原文并翻译 | 示例
           

摘要

In this article results are reviewed from different experimental approaches to determine the size of the power stroke generated by myosin molecules during their ATPase cycle. While data from fiber studies and protein crystallography predict a stroke size of about 10 nm for skeletal muscle myosins, single molecule studies imply a stroke size for these myosins of only about 5 nm. Single molecule studies also showed the stroke size to be proportional to the length of the light chain binding domain, acting like a lever arm. At the same lever arm length, however, the stroke size of smooth muscle myosin II is found about twice as large and a stroke size of about 14 nm was reported for class-I myosins. It was proposed that such different stroke sizes for molecules with same lever arm length result from different extend of converter domain rotation. Only for class-I myosins, however, an about 30° larger rotation of the converter was found so far by protein crystallography. This, however, is far too small to account for the almost 3-fold larger stroke size reported from single molecule studies. In this contribution we discuss some factors that might account for the apparent discrepancies between single molecule studies on the one hand and protein crystallography as well as some fiber studies on the other hand. In addition, we present some modeling to illustrate that the power stroke very likely is underestimated to a large extent in current single molecule approaches. We further show that differences in the stroke size for various classes of myosins reported from single molecule studies might be related to small differences in the probability to execute the power stroke kinetics. We demonstrate that such small changes in power stroke kinetics can seriously affect the extent to which the ‘true’ power stroke is underestimated by present single molecule approaches.
机译:本文对不同实验方法的结果进行了综述,以确定肌球蛋白分子在其ATPase循环过程中产生的中风大小。尽管来自纤维研究和蛋白质晶体学的数据预测骨骼肌肌球蛋白的卒中大小约为10 nm,但单分子研究表明这些肌球蛋白的卒中大小仅为约5 nm。单分子研究还显示,冲程大小与轻链结合结构域的长度成比例,就像杠杆臂一样。然而,在相同的杠杆臂长度下,发现平滑肌肌球蛋白II的冲程大小约为两倍,并且据报道I类肌球蛋白的冲程大小为约14 nm。有人提出,具有相同杠杆臂长度的分子的这种不同的冲程大小是由转换器域旋转的不同范围引起的。然而,仅对于I类肌球蛋白,到目前为止,通过蛋白质晶体学已经发现转化器旋转了约30°。但是,这太小了,不足以说明单分子研究报告的几乎每笔3倍的笔画大小。在这篇论文中,我们讨论了一些因素,这些因素一方面可以解释单分子研究与蛋白质晶体学之间的明显差异,另一方面可以解释某些纤维研究之间的差异。另外,我们提出一些模型来说明在当前的单分子方法中很可能在很大程度上低估了功率冲程。我们进一步表明,从单分子研究中报告的各种类型的肌球蛋白的卒中大小差异可能与执行动力性卒中动力学的概率的微小差异有关。我们证明,动力冲程动力学的微小变化会严重影响当前单分子方法低估“真实”动力冲程的程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号